Remove 2007 Remove Diabetes Remove Drug Pricing
article thumbnail

Why the drug pricing debate is focused on insulin

pharmaphorum

The treatment has been around for over a century but insulin has still become the centre of the ongoing discussion over pricing of pharmaceutical products. Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. In the US, approximately 37.3 In the US, approximately 37.3

article thumbnail

NHC Submits Comments to CMS RE CY 2026 Policy & Technical Changes to MA and Part D Proposed Rule

Putting Patients First Blog

The NHC recognizes that Medicare already covers AOMs for patients who are overweight and have comorbid conditions such as diabetes or cardiovascular disease. 2 (April 2007): 644662, [link] 6773.2006.00626.x. Issue Brief: Improving Prescription Drug Price and Cost Transparency. 29 Julia C. Prentice and Steven D.